1196486-69-7 Usage
General Description
Tert-butyl 4-hydrazino-piperidine-1-carboxylate is a chemical compound with the molecular formula C13H25N3O2. It is a derivative of piperidine and contains a tert-butyl group, a hydrazino group, and a carboxylate group. tert-butyl 4-hydrazino-piperidine-1-carboxylate is a valuable building block for the synthesis of various organic molecules and pharmaceuticals. It is commonly used in the field of medicinal chemistry to develop new drugs with potential therapeutic applications. Tert-butyl 4-hydrazino-piperidine-1-carboxylate has shown promise in the development of new anti-cancer and anti-inflammatory agents, as well as potential applications in the treatment of neurological disorders. Its unique chemical structure and properties make it an important intermediate in the production of various biologically active compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 1196486-69-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,9,6,4,8 and 6 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1196486-69:
(9*1)+(8*1)+(7*9)+(6*6)+(5*4)+(4*8)+(3*6)+(2*6)+(1*9)=207
207 % 10 = 7
So 1196486-69-7 is a valid CAS Registry Number.
1196486-69-7Relevant articles and documents
HETEROCYCLIC COMPOUNDS, PREPARATION METHODS THEREFOR, AND METHODS OF USES THEREOF
-
Paragraph 155, (2021/01/23)
Provided herein are novel heterocyclic compounds, for example, compounds having Formula I. Also provided herein are methods of preparing the compounds and methods of using the same, for example, in inhibiting TGF-beta mediated signaling and/or for treating cancer.
PYRAZOLE DERIVATIVES AS NHIBITORS OF THE WNT SIGNALLING PATHWAY
-
Page/Page column 6; 35, (2019/09/18)
The present invention relates to a novel class of compounds as inhibitors of the Wnt signalling pathway. The best compounds showed potencies in the low micromolar range and high efficacies (> 80%) together with good microsomal stability. Furthermore, in v
NOVEL PIPERIDINE DERIVATIVES
-
Page/Page column 72, (2016/06/28)
The invention relates to a compound of formula (I) wherein A1, A2 and R1to R3 are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament.